Carotenuto, Pietro
 Distribuzione geografica
Continente #
AS - Asia 1.617
EU - Europa 1.302
NA - Nord America 1.069
SA - Sud America 218
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.253
Nazione #
US - Stati Uniti d'America 1.022
SG - Singapore 839
RU - Federazione Russa 625
IT - Italia 385
CN - Cina 360
BR - Brasile 186
HK - Hong Kong 148
VN - Vietnam 106
DE - Germania 64
NL - Olanda 58
IN - India 46
FI - Finlandia 33
GB - Regno Unito 28
SE - Svezia 28
CA - Canada 23
KR - Corea 21
UA - Ucraina 21
ID - Indonesia 16
CI - Costa d'Avorio 14
MX - Messico 14
PK - Pakistan 14
JP - Giappone 13
AR - Argentina 12
FR - Francia 12
BD - Bangladesh 11
IQ - Iraq 10
ZA - Sudafrica 10
ES - Italia 9
EC - Ecuador 8
PL - Polonia 8
AT - Austria 7
IE - Irlanda 7
TR - Turchia 7
IR - Iran 6
KE - Kenya 6
DO - Repubblica Dominicana 5
PY - Paraguay 4
UZ - Uzbekistan 4
CO - Colombia 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
RS - Serbia 3
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
MW - Malawi 2
PE - Perù 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GF - Guiana Francese 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.253
Città #
Singapore 415
Moscow 147
Hong Kong 146
Naples 137
Ashburn 120
Hefei 120
Chandler 100
Beijing 96
Santa Clara 96
Amsterdam 48
Los Angeles 38
San Jose 35
Millbury 32
Ho Chi Minh City 28
Redondo Beach 23
Kochi 22
Lawrence 22
Orta di Atella 22
The Dalles 21
Seoul 20
Rome 19
Helsinki 18
Hanoi 16
Munich 16
Jacksonville 15
New York 15
Buffalo 14
Falkenstein 14
Milan 13
Chicago 12
Dong Ket 12
Rio de Janeiro 12
Seattle 12
São Paulo 12
Woodbridge 12
Houston 11
Montreal 11
Napoli 11
Wilmington 11
Tokyo 10
Denver 9
Nuremberg 9
Orem 9
Brooklyn 8
Dallas 8
Toronto 8
Belo Horizonte 7
Frankfurt am Main 7
London 7
Mexico City 7
Chennai 6
Council Bluffs 6
Pune 6
Turku 6
Warsaw 6
Baghdad 5
Da Nang 5
Des Moines 5
Haiphong 5
Lappeenranta 5
Salerno 5
San Francisco 5
Washington 5
Atlanta 4
Biên Hòa 4
Boston 4
Dhaka 4
Dublin 4
Ercolano 4
Guangzhou 4
Hải Dương 4
Manchester 4
Nairobi 4
Quito 4
Santo André 4
Shanghai 4
Stockholm 4
Tashkent 4
Venice 4
Almería 3
Amman 3
Bari 3
Bengaluru 3
Boardman 3
Bình Dương 3
Fairfield 3
Franca 3
Jakarta 3
Lahore 3
Mercato San Severino 3
Nanjing 3
Parma 3
Poplar 3
Portici 3
Porto Alegre 3
Pozzuoli 3
Princeton 3
Reggio Emilia 3
Salvador 3
Santo Domingo 3
Totale 2.230
Nome #
Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. 172
Integrated genomics identifies MiR-181/TFAM pathway as a critical driver of drug resistance in melanoma 172
Thyroid Cancer and Fibroblasts 153
Combination therapy with β-carotene+5-FU to overcome uL3-mediated drug resistance in p53 deleted colon cancer cells 133
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 126
Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells 123
PRUNE and NM23-M1 expression in Embryonic and Adult Mouse Brain. 122
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 120
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma 116
Targeting SLC7A11/xCT counteracts uL3mediated colorectal cancer drug resistance in 2D cell culture model and in ovo CAM xenograft 111
Role of uL3 in the crosstalk between nucleolar stress and autophagy in colon cancer cells 110
Therapeutic Approaches Targeting Nucleolus in Cancer. 109
uL3 loss sensitize resistant p53 deleted colon cancer cells to ferroptosis 107
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress 105
Pemiganitib. Fibroblast growth factor receptor inhibitor, Treatment of cholangiocarcinoma. 105
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 104
The pervasive role of the MiR-181 family in development, neurodegeneration, and cancer 103
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 101
uL3 status influences ferroptotic cell death in p53-deleted colorectal cancer cells 98
uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells 97
Optimizing response to gefitinib in the treatment of non-small-cell lung cancer 92
β-carotene plus 5-FU: a promising strategy to fight uL3-mediated drug resistance in colorectal cancer cells 91
A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation 91
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis 90
JTESS (Telencephalic Embryonic Subtractive Sequences): a Unique Collection of Neurodevelopmental Genes. 87
Novel therapeutic strategy combining β-carotene with 5-FU to overcome uL3-mediated chemoresistance in colorectal cancer cells 84
Histone Deacetylase SIRT1 promotes loss of primary cilia in Cholangiocarcinoma 84
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 84
Ribosomal protein uL3 is involved in translational reprogramming of 5-FU resistant colorectal cancer cells 82
The evolving role of fgfr2 inhibitors in intrahepatic cholangiocarcinoma: From molecular biology to clinical targeting 82
Role of uL3 in the translational reprogramming of 5-FU resistant colorectal cancer cells lacking functional p53 82
New therapeutic strategies for drug-resistant melanoma 79
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma 77
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 76
Characterisation of the immune-related transcriptome in resected biliary tract cancers 76
Spatial and temporal expressions of prune reveal a role in Müller gliogenesis during Xenopus retinal development 69
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 69
Noncoding RNAs as novel biomarkers in pancreatic cancer: What do we know? 65
Vandetanib: An overview of its clinical development in NSCLC and other tumors 64
Novel uL3-based Therapeutic Approaches to Treat Colon Cancer Devoid of p53 61
Ribosomal protein uL3 as regulator of ferroptosis in 5-FU resistance 60
Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay 59
Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach 50
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth 48
Prognostic applications of gene expression signatures in breast cancer 45
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy 44
Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies 42
Triple negative breast cancer: From molecular portrait to therapeutic intervention 34
Totale 4.354
Categoria #
all - tutte 13.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 4 1 17 11 9 13
2021/2022118 4 4 0 2 0 2 0 5 26 21 9 45
2022/2023337 25 8 8 9 45 49 5 38 58 49 32 11
2023/2024319 14 39 51 15 18 41 12 30 7 10 63 19
2024/20251.588 50 39 8 100 64 152 165 122 78 168 534 108
2025/20261.809 288 290 289 285 496 115 46 0 0 0 0 0
Totale 4.354